Suchergebnisse - "Sala, Luca"

PubPharm (7)

1

Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: the case of hydroxychloroquine in COVID-19

enthalten in: bioRxiv.org | 2022

von Sala, L. | Leonov, V. | Mura, M. | +4

2

Correction to : Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

enthalten in: Journal of translational medicine | 2021

von Perrone, F. | Piccirillo, M. | Ascierto, P. | +134

ErratumFor: J Transl Med. 2020 Oct 21;18(1):405. - PMID 33087150

3

The Quick Walk Test : A Noninvasive Test to Assess the Risk of Mechanical Ventilation During COVID-19 Outbreaks

enthalten in: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine | 2021

von Paglia, S. | Nattino, G. | Occhipinti, F. | +19

4

Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs : The Case of Hydroxychloroquine in COVID-19

enthalten in: Frontiers in physiology | 2021

von Sala, L. | Leonov, V. | Mura, M. | +6

5

The Role for Tocilizumab in COVID-19 Patients : Reflections on Monza Cohort Data

enthalten in: Infection and drug resistance | 2021

von Capici, S. | Sala, L. | Galimberti, S. | +5

6

Feasibility and efficacy of home monitoring for patients with suspected or confirmed COVID-19.

enthalten in: Recenti progressi in medicina | 2020

von Banzi, R. | Sala, L. | Colmi, A. | +6

7

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

enthalten in: Journal of translational medicine | 2020

von Perrone, F. | Piccirillo, M. | Ascierto, P. | +134

ErratumIn: J Transl Med. 2021 Oct 21;19(1):442. - PMID 34674735

1
[1]